CIP
LUMO

Convergence Investment Partners’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Convergence Investment Partners’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-846
Closed -$277K – 404
2015
Q4 		$277K Buy
+846
New +$275K 0.03% 304
2015
Q3 		– Sell
-5,457
Closed -$2.17M – 423
2015
Q2 		$2.17M Buy
5,457
+3,030
+125% +$1.29M 0.21% 157
2015
Q1 		$1.2M Buy
+2,427
New +$940K 0.17% 233

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Convergence Investment Partners's LUMO Position: Q1 2016 in Review

Convergence Investment Partners sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2016, closing a stake of 846 shares — an estimated $277K sold.

Convergence Investment Partners first reported a position in LUMO in Q1 2015 and held it in 3 quarters. The position peaked at $2.17M in Q2 2015. 139 funds tracked by Wall St. Rank hold LUMO as of Q1 2016.

  • Convergence Investment Partners reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Convergence Investment Partners sold 846 Lumos Pharma, Inc. Common Stock shares in Q1 2016, an estimated $277K.
  • Convergence Investment Partners first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Convergence Investment Partners's Lumos Pharma, Inc. Common Stock position peaked at $2.17M in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2016.

Based on Convergence Investment Partners's 13F filing for Q1 2016, filed 11 May 2016.